- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.80 Å
- Oligo State
- hetero-3-3-mer
- Ligands
- 12 x PO4: PHOSPHATE ION(Non-functional Binders)
- 24 x CL: CHLORIDE ION(Non-functional Binders)
CL.2: 8 residues within 4Å:- Chain A: K.105, Y.116
- Chain C: K.105, Y.116
- Chain E: K.105, Y.116
- Ligands: CL.15, CL.28
Ligand excluded by PLIPCL.3: 3 residues within 4Å:- Chain A: W.107, H.114
- Chain C: T.104
Ligand excluded by PLIPCL.4: 4 residues within 4Å:- Chain A: F.124, K.125
- Chain B: K.84
- Chain E: K.38
Ligand excluded by PLIPCL.5: 4 residues within 4Å:- Chain A: Y.31, H.32, D.33, R.34
Ligand excluded by PLIPCL.6: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPCL.11: 5 residues within 4Å:- Chain B: Y.75, H.88, K.89, P.108, R.109
Ligand excluded by PLIPCL.12: 2 residues within 4Å:- Chain B: H.118, N.120
Ligand excluded by PLIPCL.13: 1 residues within 4Å:- Chain E: D.145
Ligand excluded by PLIPCL.15: 8 residues within 4Å:- Chain A: K.105, Y.116
- Chain C: K.105, Y.116
- Chain E: K.105, Y.116
- Ligands: CL.2, CL.28
Ligand excluded by PLIPCL.16: 3 residues within 4Å:- Chain C: W.107, H.114
- Chain E: T.104
Ligand excluded by PLIPCL.17: 4 residues within 4Å:- Chain A: K.38
- Chain C: F.124, K.125
- Chain D: K.84
Ligand excluded by PLIPCL.18: 4 residues within 4Å:- Chain C: Y.31, H.32, D.33, R.34
Ligand excluded by PLIPCL.19: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPCL.24: 5 residues within 4Å:- Chain D: Y.75, H.88, K.89, P.108, R.109
Ligand excluded by PLIPCL.25: 2 residues within 4Å:- Chain D: H.118, N.120
Ligand excluded by PLIPCL.26: 1 residues within 4Å:- Chain A: D.145
Ligand excluded by PLIPCL.28: 8 residues within 4Å:- Chain A: K.105, Y.116
- Chain C: K.105, Y.116
- Chain E: K.105, Y.116
- Ligands: CL.2, CL.15
Ligand excluded by PLIPCL.29: 3 residues within 4Å:- Chain A: T.104
- Chain E: W.107, H.114
Ligand excluded by PLIPCL.30: 4 residues within 4Å:- Chain C: K.38
- Chain E: F.124, K.125
- Chain F: K.84
Ligand excluded by PLIPCL.31: 4 residues within 4Å:- Chain E: Y.31, H.32, D.33, R.34
Ligand excluded by PLIPCL.32: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPCL.37: 5 residues within 4Å:- Chain F: Y.75, H.88, K.89, P.108, R.109
Ligand excluded by PLIPCL.38: 2 residues within 4Å:- Chain F: H.118, N.120
Ligand excluded by PLIPCL.39: 1 residues within 4Å:- Chain C: D.145
Ligand excluded by PLIP- 3 x NA: SODIUM ION(Non-functional Binders)
NA.10: 5 residues within 4Å:- Chain B: C.132, A.133, F.136, S.159, V.161
3 PLIP interactions:3 interactions with chain B- Hydrogen bonds: B:C.132, B:S.159, B:S.163
NA.23: 5 residues within 4Å:- Chain D: C.132, A.133, F.136, S.159, V.161
3 PLIP interactions:3 interactions with chain D- Hydrogen bonds: D:S.159, D:V.161, D:S.163
NA.36: 5 residues within 4Å:- Chain F: C.132, A.133, F.136, S.159, V.161
3 PLIP interactions:3 interactions with chain F- Hydrogen bonds: F:S.159, F:S.159, F:S.163
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Liu, C. et al., A RANKL mutant used as an inter-species vaccine for efficient immunotherapy of osteoporosis. Sci Rep (2015)
- Release Date
- 2015-10-14
- Peptides
- Tumor necrosis factor ligand superfamily member 11: ACE
Tumor necrosis factor receptor superfamily member 11A: BDF - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AC
AE
AB
RD
RF
R
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.80 Å
- Oligo State
- hetero-3-3-mer
- Ligands
- 12 x PO4: PHOSPHATE ION(Non-functional Binders)
- 24 x CL: CHLORIDE ION(Non-functional Binders)
- 3 x NA: SODIUM ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Liu, C. et al., A RANKL mutant used as an inter-species vaccine for efficient immunotherapy of osteoporosis. Sci Rep (2015)
- Release Date
- 2015-10-14
- Peptides
- Tumor necrosis factor ligand superfamily member 11: ACE
Tumor necrosis factor receptor superfamily member 11A: BDF - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AC
AE
AB
RD
RF
R